AuntMinnie.com staff writersMolecular ImagingNorthStar inks supply deal with ClarityNorthStar Medical Radioisotopes parent NorthStar Medical Technologies has signed a letter of intent to supply radiopharmaceutical firm Clarity Pharmaceuticals with copper-67.February 11, 2020BreastFDA reinstates Raleigh Radiology's accreditationThe U.S. Food and Drug Administration (FDA) on February 11 announced that it had reinstated accreditation for a facility in Raleigh, NC, that had experienced mammography technical quality issues.February 11, 2020Radiation Oncology/TherapyVarian gets FDA nod for Ethos adaptive therapy unitRadiation therapy firm Varian Medical Systems has garnered U.S. Food and Drug Administration (FDA) clearance for its Ethos system, a radiation therapy platform that utilizes artificial intelligence to adapt treatments in real-time to changes in tumors and patient anatomy.February 10, 2020Digital X-RaySiemens brings Artis Icono biplane to U.S.Siemens Healthineers has installed its first Artis icono biplane angiography system in the U.S.February 10, 2020Industry NewsTrump's 2021 budget calls for 8% NIH cutU.S. President Donald Trump on February 10 released a proposed budget for 2021 that includes an 8% cut in funding to the U.S. National Institutes of Health (NIH), proposing a 2021 budget of $38 billion, compared with the $41.4 billion for 2020.February 10, 20202020ESR anticipates record-breaking participation at ECR 2020The European Society of Radiology (ESR) expects the number of attendees at the upcoming ECR 2020 in Vienna to reach an all-time high.February 10, 2020Advanced VisualizationStratasys launches new multicolor midrange 3D printer3D printing technology firm Stratasys unveiled a new 3D printer that offers multicolor and multimaterial 3D printing at half the cost of previous printers with matching capabilities.February 10, 2020Nuclear MedicineInternational Isotopes receives FDA nod for I-131Radioisotope manufacturer International Isotopes received clearance from the U.S. Food and Drug Administration (FDA) for use of its sodium iodide-131 (I-131) radiopharmaceutical to treat hyperthyroidism and thyroid carcinomas.February 10, 2020ISChange Healthcare issues 2020 healthcare industry reportHealthcare information systems vendor Change Healthcare has published its annual report on the status of the healthcare industry and on the expected challenges and opportunities awaiting the field in 2020.February 10, 2020Industry NewsU.S. House releases plan to address surprise medical billingThe U.S. House of Representatives' Ways and Means Committee on February 7 released text of new legislation that would address surprise medical billing.February 9, 2020Previous PagePage 431 of 3774Next PageTop StoriesNuclear MedicineWhat are patients being told before, during, and after Lu-177 RPT?The recommended duration for maintaining distance from others after treatment ranged from one to three days at some sites and up to seven days at others.MedicolegalRadiology group sues Lovelace over poaching, cyberattack falloutPractice ManagementCMS final rule draws mixed responseIndustry NewsSiemens Healthineers posts strong Q4, plans name changeSponsor ContentFREE webinar: find your imaging capacity
